Ozempic Lawsuits allege that manufacturers Novo Nordisk and Eli Lilly, which also produces GLP-1 drugs, failed to adequately warn users about the potential for severe side effects such as gastroparesis (a condition causing delayed stomach emptying), intestinal obstruction, and other gastrointestinal injuries associated with these medications
Explore the full Peptides & GLP-1 library
Track body measurements monthly
Targeting Obesity: GLP-1R/GIPR, GDF8 Leading the Way Rising Obesity Rates: A Global Threat Obesity, a chronic metabolic disease, has significantly impacted the health and quality of life for countless individuals
The guide to tirzepatide injection in the thigh covers the specific positioning and needle angle for that alternative site
Gut to Brain Dysbiosis: Mechanisms Linking Western Diet Consumption, the Microbiome, and Cognitive Impairment